SAIC (NYSE:SAI) was downgraded by JP Morgan (NYSE:JPM) to neutral from overweight with a price target of $12 as the firm believes the stock price is fully valued, given that the company has outperformed peers by 13% this year.
Shares are lower by about 4.5 percent.
Vivus (NASDAQ:VVUS) had its estimates and price target reduced by JMP (NYSE:JMP) due to lower sales of Qsymia. An outperform rating was issued with a price target of $30.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.